| | | | | | | |
 | VERTEX PHARMACEUTICALS | 0.81% | 3.75% | 11.70% | 32.72% | 42.07% | 82 136 |
 | REGENERON PHARMACEUTICALS, INC. | 2.82% | 2.89% | 4.95% | 24.42% | 124.07% | 78 655 |
 | WUXI APPTEC CO., LTD. | -3.21% | -1.56% | 15.12% | -11.02% | 63.55% | 41 845 |
 | BIONTECH SE | 2.19% | 0.61% | -4.43% | -16.57% | 391.48% | 34 142 |
 | BEIGENE, LTD. | 0.04% | -4.78% | 16.51% | 5.64% | 68.19% | 26 628 |
 | GENMAB A/S | 0.38% | -2.17% | -9.15% | 19.77% | 71.56% | 25 417 |
 | ARGENX SE | 0.12% | -4.52% | -0.37% | 48.10% | 166.72% | 20 887 |
 | SAREPTA THERAPEUTICS, INC. | 2.58% | -5.82% | -4.32% | 73.23% | 6.92% | 10 609 |
 | NEUROCRINE BIOSCIENCES, INC. | 1.85% | -0.42% | -7.66% | 39.57% | 10.20% | 10 410 |
 | LEGEND BIOTECH CORPORATION | 1.51% | -7.13% | 1.93% | 19.34% | --.--% | 8 392 |
 | HALOZYME THERAPEUTICS, INC. | 0.65% | -0.58% | -9.58% | 48.66% | 171.07% | 6 912 |
 | ASCENDIS PHARMA A/S | 1.82% | -2.42% | 0.71% | 1.12% | -8.96% | 6 764 |
 | KARUNA THERAPEUTICS, INC. | 2.04% | -0.76% | 1.26% | 79.16% | 109.65% | 6 701 |
 | REMEGEN CO., LTD. | -2.40% | -2.27% | 8.81% | 30.98% | --.--% | 5 929 |
 | EXELIXIS, INC. | 1.18% | 2.17% | 9.69% | -2.79% | 2.30% | 5 609 |
| | | | | | | |
| Durchschnitt | 0.83% | -1.53% | 2.35% | 26.15% | 93.75% | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 0.87% | 0.17% | 5.32% | 20.57% | 107.66% | |